Full-Time

Head of Clinical Operations

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Expert

Cambridge, MA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Flagship Pioneering's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Minimum 10 years of experience in clinical operations across at least 2 therapeutics areas, including rare diseases and oncology
  • Experience managing Phase 1 dose-finding trials (in Healthy Volunteers or in patients)
  • Experience leading patient-finding initiatives, especially those requiring genetic testing, to support clinical trial enrollment
  • Experience managing CROs and vendors both in the US and in international clinical trials
  • Experience in site initiation visits, site management, data cuts for publication and regulatory requirements
  • Understanding of the drug development process from IND to NDA/BLA
  • Dedication to collaborative work in a fast-paced environment; open-mindedness to shifting strategy in a data-guided manner
  • Ability to communicate effectively and efficiently and willingness to train other team-members within and outside of Clinical Operations
Responsibilities
  • Develop clinical operations strategy for each agent in development, either directly or by leading study staff depending on the stage of the pipeline
  • Cross-functional collaboration to develop needed outputs such as protocols, annual safety reports and investigator brochure, clinical study reports, presentations, regulatory submissions, and publications
  • Evaluate external collaborators including Contract Research Organizations (CROs) and sites and select the best candidates for each needed function. Develop vendor scope of work, contract, quality, monitoring, and budget
  • Develop and lead patient finding and recruitment strategy, planning, and forecasting
  • Develop and manage standard operating procedures (SOPs) for the organization and its external collaborators. Ensure GCP (Good Clinical Practice) compliance
  • Continuously evaluate performance of external collaborators and vendors, troubleshoot and recommend a path forward when challenges are encountered
  • Develop and manage study timelines, working with internal partners (including but not limited to clinical development, clinical pharmacology and other quantitative functions, data management, biomarkers and translational, CMC, regulatory affairs, and project management)
  • Attend and, where appropriate, present at study site initiation meetings and study calls
Desired Qualifications
  • Experience in large Pharma and biotech and with biomarker-selected studies preferred but not required
  • Experience with at least one report is preferred, but a strong candidate with hands-on experience and a growth mindset will be considered

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.2B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.
  • Strategic partnerships with Pfizer enhance drug discovery and development capabilities.
  • Inari Agriculture's $2.17 billion valuation highlights successful investment strategy.

What critics are saying

  • Over-reliance on strategic partnerships with large pharmaceutical companies poses potential risks.
  • High-profile executive appointments may lead to cultural clashes within teams.
  • Focus on first-in-category ventures may result in higher R&D costs and longer profitability timelines.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • Combines innovative capacity, entrepreneurial leadership, and capital management in one enterprise.
  • Uses evolutionary methodology to navigate from unreasonable propositions to transformational outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

Contract Pharma
Feb 19th, 2025
YourBio Health Taps Paul Owen as CEO

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.

PR Newswire
Jan 23rd, 2025
Flagship Pioneering, Cambridge University Health Partners, And Milner Therapeutics Institute Announce Collaboration To Accelerate Biotech Research And Innovation

First of its Kind Scientific Collaboration Will Engage Top Research Institutes in Cambridge, UK with Flagship PioneeringFocus on Scaling and Advancing Flagship's Breakthrough Science and Technologies through the Cambridge Life Sciences EcosystemLONDON, Jan. 23, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced an agreement with top life science organisations Cambridge University Health Partners (CUHP) and the Milner Therapeutics Institute (MTI) to collaborate to jointly advance breakthrough scientific research and technologies

Genetic Engineering & Biotechnology News
Jan 8th, 2025
Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

The following year, Flagship Pioneering formally announced the launch of privately-held Valo, joining with other undisclosed investors to bring the company's total financing to nearly $100 million.

Bloomberg
Jan 7th, 2025
Ag Tech Startup Inari Gets $2.17 Billion Valuation in Latest Funding Round

Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a roughly 32% jump from a prior mark of $1.65 billion set last January.

Contract Pharma
Nov 21st, 2024
Flagship Pioneering Enters Agreements Under Strategic Pfizer Pact

Flagship Pioneering, a bioplatform company, entered agreements with Ampersand Biomedicines and Montai Therapeutics to identify targeted molecules that could be further developed as treatments for obesity and non-small cell lung cancer (NSCLC).